Skip to main content
Log in

Severe Cardiomyopathy Due to Arthroprosthetic Cobaltism: Report of Two Cases with Different Outcomes

  • Published:
Cardiovascular Toxicology Aims and scope Submit manuscript

Abstract

Cobalt-induced cardiomyopathy is a well-known but uncommon disease, and the physician must maintain a high index of suspicion in order to make a timely diagnosis. We report two patients with cobalt-induced cardiomyopathy. Both patients developed progressively worsening symptoms of cobalt toxicity following revision of a fractured ceramic-on-ceramic total hip replacement to a metal-on-polyethylene bearing. In both patients, echocardiography showed LV hypertrophy, biventricular systolic dysfunction, and a large amount of pericardial effusion. Due to decompensated heart failure, both patients were initially considered candidates for heart transplantation. One patient was diagnosed with cobalt-induced cardiomyopathy before transplantation. He received cobalt chelation therapy and revision surgery, which led to complete recovery of heart function. In the other patient, the diagnosis was not made until the time of heart transplantation. The gross examination of the explanted heart revealed typical features of cobalt cardiotoxicity, which was then diagnosed as cobalt-induced cardiomyopathy. These cases emphasise the importance of early diagnosis and prompt treatment of cobalt intoxication.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Gilbert, C. J., et al. (2013). Hip pain and heart failure: The missing link. Canadian Journal of Cardiology, 29(5), 639e1–e2.

    Article  Google Scholar 

  2. Machado, C., Appelbe, A., & Wood, R. (2012). Arthroprosthetic cobaltism and cardiomyopathy. Heart, Lung and Circulation, 21(11), 759–760.

    Article  PubMed  Google Scholar 

  3. van Lingen, C. P., et al. (2013). Clinical manifestations in ten patients with asymptomatic metal-on-metal hip arthroplasty with very high cobalt levels. Hip International, 23(5), 441–444.

    Article  PubMed  Google Scholar 

  4. Oldenburg, M., Wegner, R., & Baur, X. (2009). Severe cobalt intoxication due to prosthesis wear in repeated total hip arthroplasty. The Journal of Arthroplasty, 24(5), 825 e15–e20.

    Article  Google Scholar 

  5. Cheung, A. C., et al. (2016). Systemic cobalt toxicity from total hip arthroplasties: Review of a rare condition Part 1—History, mechanism, measurements, and pathophysiology. The Bone & Joint Journal, 98-b(1), 6–13.

    Article  CAS  Google Scholar 

  6. Gessner, B. D., et al. (2015). A systematic review of systemic cobaltism after wear or corrosion of chrome-cobalt hip implants. Journal of Patient Safety, 0, 1–8

    Article  Google Scholar 

  7. Tower, S. S. (2010). Arthroprosthetic cobaltism: Neurological and cardiac manifestations in two patients with metal-on-metal arthroplasty: A case report. The Journal of Bone and Joint Surgery, 92(17), 2847–2851.

    Article  PubMed  Google Scholar 

  8. Catalani, S., et al. (2012). Neurotoxicity of cobalt. Human & Experimental Toxicology, 31(5), 421–437.

    Article  CAS  Google Scholar 

  9. Mosier, B. A., Maynard, L., Sotereanos, N. G., Sewecke, J. J. (2016). Progressive cardiomyopathy in a patient with elevated cobalt ion levels and bilateral metal-on-metal hip arthroplasties. The American Journal of Orthopedics, 45(3), E132–E135.

    PubMed  Google Scholar 

  10. Zywiel, M. G., et al. (2013). Fatal cardiomyopathy after revision total hip replacement for fracture of a ceramic liner. The Bone & Joint Journal, 95(1), 31–37.

    Article  Google Scholar 

  11. Allen, L. A., et al. (2014). Clinical problem-solving. Missing elements of the history. The New England Journal of Medicine, 370(6), 559–566.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Samar, H. Y., et al. (2015). Novel use of cardiac magnetic resonance imaging for the diagnosis of cobalt cardiomyopathy. JACC Cardiovasc Imaging, 8(10), 1231–1232.

    Article  PubMed  Google Scholar 

  13. Kempf, I., & Semlitsch, M. (1990). Massive wear of a steel ball head by ceramic fragments in the polyethylene acetabular cup after revision of a total hip prosthesis with fractured ceramic ball. Archives of Orthopaedic and Trauma Surgery, 109(5), 284–287.

    Article  CAS  PubMed  Google Scholar 

  14. Morin, Y., Tetu, A., & Mercier, G. (1971). Cobalt cardiomyopathy: Clinical aspects. British Heart Journal, 33(p. Suppl), 175–178.

    Article  PubMed Central  Google Scholar 

  15. Morin, Y., Tetu, A., & Mercier, G. (1969). Quebec beer-drinkers’ cardiomyopathy: Clinical and hemodynamic aspects. Annals of the New York Academy of Sciences, 156(1), 566–576.

    Article  CAS  PubMed  Google Scholar 

  16. Alexander, C. S. (1972). Cobalt-beer cardiomyopathy. A clinical and pathologic study of twenty-eight cases. The American Journal of Medicine, 53(4), 395–417.

    Article  CAS  PubMed  Google Scholar 

  17. Tilney, R., Burg, M. R., & Sammut, M. A., (2017). Cobalt cardiomyopathy secondary to hip arthroplasty: An increasingly prevalent problem. Case Reports in Cardiology, 2017, 5434571.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Pandit, H., et al. (2008). Pseudotumours associated with metal-on-metal hip resurfacings. The Journal of Bone and Joint Surgery British, 90(7), 847–851.

    Article  CAS  Google Scholar 

  19. Polyzois, I., et al. (2012). Local and systemic toxicity of nanoscale debris particles in total hip arthroplasty. Journal of Applied Toxicology, 32(4), 255–269.

    Article  CAS  PubMed  Google Scholar 

  20. Gill, H. S., et al. (2012). Molecular and immune toxicity of CoCr nanoparticles in MoM hip arthroplasty. Trends in Molecular Medicine, 18(3), 145–155.

    Article  CAS  PubMed  Google Scholar 

  21. Papageorgiou, I., et al. (2007). The effect of nano- and micron-sized particles of cobalt-chromium alloy on human fibroblasts in vitro. Biomaterials, 28(19), 2946–2958.

    Article  CAS  PubMed  Google Scholar 

  22. Tower, S. (2010). Arthroprosthetic cobaltism: Identification of the at-risk patient. Alaska Medicine, 52, 28–32.

    PubMed  Google Scholar 

  23. Sotos, J. G., & Tower, S. S. (2013). Systemic disease after hip replacement: Aeromedical implications of arthroprosthetic cobaltism. Aviation, Space, and Environmental Medicine, 84(3), 242–245.

    Article  PubMed  Google Scholar 

  24. Heggtveit, H. A., Grice, H. C., & Wiberg, G. S. (1970). Cobalt cardiomyopathy. Experimental basis for the human lesion. Pathologia et Microbiologia (Basel), 35(1), 110–113.

    CAS  Google Scholar 

  25. Dingle, J. T., et al. (1962). The biological action of cobalt and other metals. II. The mechanism of the respiratory inhibition produced by cobalt in mammalian tissues. Biochimica et Biophysica Acta, 65, 34–46.

    Article  CAS  PubMed  Google Scholar 

  26. Rona, G., (1971). Experimental aspects of cobalt cardiomyopathy. British Heart Journal, 33(Suppl), 171–174.

    Article  Google Scholar 

  27. Harrow, J. A., Das, P. K., & Dhalla, N. S. (1978). Influence of some divalent cations on heart sarcolemmal bound enzymes and calcium binding. Biochemical Pharmacology, 27(22), 2605–2609.

    Article  CAS  PubMed  Google Scholar 

  28. Barceloux, D. G. (1999). Cobalt. Journal of Toxicology: Clinical Toxicology, 37(2), 201–206.

    CAS  PubMed  Google Scholar 

  29. Unverferth, D. V., et al. (1984). The evolution of beta-adrenergic dysfunction during the induction of canine cobalt cardiomyopathy. Cardiovascular Research, 18(1), 44–50.

    Article  CAS  PubMed  Google Scholar 

  30. Seghizzi, P., et al. (1994). Cobalt myocardiopathy. A critical review of literature. Science of the Total Environment, 150(1–3), 105–109.

    Article  CAS  PubMed  Google Scholar 

  31. Tabel, G. M., et al. (2006). Collagen fiber morphology determines echogenicity of myocardial scar: Implications for image interpretation. Echocardiography, 23(2), 103–107.

    Article  PubMed  Google Scholar 

  32. Mohiuddin, S. M., et al. (1970). Experimental cobalt cardiomyopathy. American Heart Journal, 80(4), 532–543.

    Article  CAS  PubMed  Google Scholar 

  33. Giampreti, A., Lonati, D., & Locatelli, C. A. (2014). Chelation in suspected prosthetic hip-associated cobalt toxicity. Canadian Journal of Cardiology, 30(4), 465.e13.

    Article  PubMed  Google Scholar 

  34. Devlin, J. J., Schwartz, M., & Brent, J. (2013). Chelation in suspected prosthetic hip-associated cobalt toxicity. Canadian Journal of Cardiology, 29(11), 1533.e7.

    Article  PubMed  Google Scholar 

  35. Smith, S. W. (2013). The role of chelation in the treatment of other metal poisonings. Journal of Medical Toxicology, 9, 355–369.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Pazzaglia, U. E., et al. (2011). Cobalt, chromium and molybdenum ions kinetics in the human body: Data gained from a total hip replacement with massive third body wear of the head and neuropathy by cobalt intoxication. Archives of Orthopaedic and Trauma Surgery, 131(9), 1299–1308.

    Article  CAS  PubMed  Google Scholar 

  37. Repo, E., et al. (2011). Capture of Co(II) from its aqueous EDTA-chelate by DTPA-modified silica gel and chitosan. Journal of Hazardous Materials, 187(1–3), 122–132.

    Article  CAS  PubMed  Google Scholar 

  38. Giampreti, A., et al. (2016). N-acetyl-cysteine as effective and safe chelating agent in metal-on-metal hip-implanted patients: Two cases. Case Reports in Orthopedics, 2016, 8682737.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Asapoglu, N. K., Toprak, A. B.,M. S., Koseoglu, Y., & Bayrakdar, H. (2000). Synthesis and characterization of NiFe ~ 2O ~ 4 nano-octahedrons by EDTA-assisted hydro-thermal method. Turkish Journal of Chemistry, 30, 659–666.

    Google Scholar 

  40. Kwon, Y. M., et al. (2014). Risk stratification algorithm for management of patients with dual modular taper total hip arthroplasty: Consensus statement of the American Association of Hip and Knee Surgeons, the American Academy of Orthopaedic Surgeons and the Hip Society. The Journal of Arthroplasty, 29(11), 2060–2064.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hyo-In Choi.

Additional information

Handling Editor: Y. James Kang.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Choi, HI., Hong, J.A., Kim, MS. et al. Severe Cardiomyopathy Due to Arthroprosthetic Cobaltism: Report of Two Cases with Different Outcomes. Cardiovasc Toxicol 19, 82–89 (2019). https://doi.org/10.1007/s12012-018-9480-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12012-018-9480-0

Keywords

Navigation